Skip Navigation
Text Size: A  A  A
Genetic and Rare Diseases Information Center (GARD)


Other names people use for this condition
  • Kasabach Merritt syndrome
  • Thrombocytopenia-hemangioma syndrome
  • Kasabach Merritt phenomenon
  • KMP



Hemangioma thrombocytopenia syndrome
ORDR lists rare diseases for information purposes only and does not guarantee that a condition is rare. Read more
The links on this page may take you to sites outside of the NIH. (See Disclaimer for details.)


Hemangioma thrombocytopenia syndrome is characterized by profound thrombocytopenia in association with two rare vascular tumors: kaposiform hemangioendotheliomas and tufted angiomas. The profound thrombocytopenia can cause life threatening bleeding and progress to a disseminated coagulopathy in patients with these tumors.[1][2] The condition typically occurs in early infancy or childhood, although prenatal cases (diagnosed with the aid of ultrasonography), newborn presentations, and rare adult cases have been reported.[3]


References
  1. Adams D. Kasabach-Merritt phenomenon. National Organization for Rare Disorders (NORD). 2008 Available at: http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Kasabach-Merritt%20phenomenon. Accessed October 19, 2010.
  2. Vazquez MP. Kasabach-Merritt syndrome. Orphanet. 2006 Available at: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=2330. Accessed October 19, 2010.
  3. Krafchik BR, Hendricks LK, Faguet GB, Kuthiala S. Kasabach-Merritt Syndrome. eMedicine. 2010 Available at: http://emedicine.medscape.com/article/202455-overview. Accessed October 19, 2010.
click to take you to contact us form

Questions & Answers
If you would like to submit a question, Contact GARD
For more information about Hemangioma thrombocytopenia syndrome click on the boxes below:
More Detailed Information Organizations Services Scientific Conferences Clinical Trials & Research